[Translated article] Requirements for Accessing New Dermatology Drugs in Spain : Results of the EQUIDAD Study Condicionantes de acceso a nuevos medicamentos dermatológicos en España: resultados del proyecto EQUIDAD
Sánchez-Díaz, Manuel (Servicio de Dermatología. Hospital Universitario Virgen de las Nieves. Instituto de Investigación Biosanitaria IBS)
Flórez, Ángeles (Complejo Hospitalario Universitario de Pontevedra)
Ara-Martín, Mariano (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza)
Arias-Santiago, Salvador (Hospital Universitario Virgen de las Nieves (Granada))
Botella-Estrada, Rafael (Hospital Universitari i Politècnic La Fe (València))
Cañueto-Álvarez, Javier (Hospital Clínico Universitario (Salamanca))
Carretero-Hernández, Gregorio (Hospital Universitario de Gran Canaria Dr. Negrín)
Coto-Segura, P. (Hospital Álvarez-Buylla (Mieres, Astúries))
de Eusebio-Murillo, Esther (Hospital Universitario de Guadalajara)
García-Latasa de Araníbar, Francisco Javier (Hospital Royo Villanova)
García-Patos Briones, Vicente (Hospital Universitari Vall d'Hebron)
Gardeazabal-García, Jesús (Hospital Universitario de Cruces (Barakaldo, País Basc))
Gómez-Fernández, Cristina (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria))
Hernández-Ostiz, Sergio (Hospital de Calahorra)
Izu, Rosa Maria (Hospital Universitario de Basurto (Bilbao, Biscaia))
López-Ávila, Ángel (Hospital General Universitario Santa María del Rosell)
Manchado-López, Pilar (Hospital Clínico Universitario de Valladolid)
Martín-Santiago, Ana (Hospital Universitari Son Espases (Palma de Mallorca, Balears))
Martinez de Espronceda-Ezquerro, Íñigo (Hospital San Pedro de Alcántara)
Mateu Puchades, Almudena (Hospital Universitari Doctor Peset (València))
Mercader-García, Pedro (Hospital General Universitario Morales Meseguer (Múrcia))
Notario-Rosa, Jaime (Hospital Universitari de Bellvitge)
Palacio-Aller, Lucía (Hospital Universitario de Cabueñes (Gijón))
Pérez-Hortet, Cristina (Complejo Hospitalario de Toledo)
Quintana-Castanedo, Lucía (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria))
Rivera, Raquel (Hospital 12 de Octubre (Madrid))
Rocamora-Duran, Vicenç (Hospital de Manacor (Manacor, Illes Balears))
Rodríguez-Nevado, Isabel Mª (Complejo Hospitalario Universitario de Badajoz)
Ruíz Villaverde, Ricardo (Hospital Universitario San Cecilio (Granada))
Fundora-Suárez, Jiliam (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife))
Trasobares-Marugán, Lidia (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid))
Vizán-de Uña, Carmen (Hospital Universitario de Cáceres)
Yanguas, Ignacio (Complejo Hospitalario de Navarra)
Zulaica-Garate, Ander (Hospital do Meixoeiro (Vigo, Galícia))
García-Doval, Ignacio (Fundación Piel Sana AEDV (Madrid))
Descalzo-Gallego, Miguel Ángel (Fundación Piel Sana AEDV (Madrid))
Grau-Pérez, Mercè (Hospital Universitario Puerta de Hierro Majadahonda (Madrid))
Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)

Data:	2024
Resum:	Background: Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities. Material and methods: Cross-sectional study conducted in April and May, 2023. Two dermatologists with management responsibilities from each autonomous community reported on territorial and more local prescription requirements for drugs covered by national TPRs issued between 2016 and 2022. Results: Thirty-three researchers from 17 autonomous communities participated. The data submitted revealed between-community inequities in access to new drugs. Overall, 64. 7% of the regions imposed additional prescription requirements to those mentioned in the TPRs for psoriasis. This percentage was lower for atopic dermatitis (35. 3%) and melanoma (11. 8%). The most common requirement for accessing a new drug was a previous prescription for another drug. Differences and additional requirements were also detected at the local level (i. e. , differences between hospitals within the same autonomous community). Conclusions: Spain's autonomous communities have multiple regional and local prescription requirements that are not aligned with national TPR recommendations. These differences result in inequitable access to new drugs for both patients and practitioners across Spain.
Nota:	This study was possible thanks to the Juan de Azúa Grant awarded by Piel Sana Foundation attached to the Spanish Academy of Dermatology and Venereology.
Drets:	Aquest material està protegit per drets d'autor i/o drets afins. Podeu utilitzar aquest material en funció del que permet la legislació de drets d'autor i drets afins d'aplicació al vostre cas. Per a d'altres usos heu d'obtenir permís del(s) titular(s) de drets.
Llengua:	Castellà
Document:	Article ; recerca ; Versió publicada
Matèria:	Equity ; Drugs-Psoriasis ; Atopic dermatitis ; Oncology ; Spain
Publicat a:	Actas dermo-sifiliográficas, Vol. 115 Núm. 3 (marzo 2024) , p. T237-T245, ISSN 1578-2190

DOI: 10.1016/j.ad.2024.01.019

9 p, 754.9 KB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Articles > Articles de recerca
Articles > Articles publicats